Two items noticed in the Monday announcements.
Webinar - There's a webinar on device reimbursement and FDA breakthrough status, Wednesday November 3, 10 PT / 1 ET. It's produced by Allison Komiyama of AcKnowledge regulatory consultancy, and Mark Domyahn of JD Lymon Group. Register here.
Roche launches a (non-FDA-approved) kit "designed to match Foundation Medicine CDx panel content" with 324 genes. Read the details at Pharma Times, here.
